Medlir is joined by Dr. Nafiseh (Cati) Molaei, a Postdoctoral Scholar specializing in Biomedical Data Science at Northwestern University to discuss how AI is reshaping the medical landscape. From diagnosing complex diseases to personalizing treatment plans, AI is driving innovations that were once thought impossible.

Links:

• https://datascience.uchicago.edu/events/nafiseh-cati-mollaei-uchicago-aiscience-schmidt-fellows-speaker-series/
• https://www.healthaffairs.org/doi/epdf/10.1377/hlthaff.2024.01003
• https://www.nature.com/articles/s41591-024-03097-1

Send us a text

Today we dive into the evolving conversation on AI risk and governance. Our guests, Torben Swoboda and Risto Uuk, discuss the challenges of defining AI risk, the debate over acceptable thresholds, and common critiques of the existential risk perspective. We also examine the feasibility of global AI governance and historical parallels that may guide our path forward.

Links:

• Examining Popular Arguments Against AI Existential Risk: A Philosophical Analysis
• Pause Giant AI Experiments: An Open Letter

Send us a text

In this episode Ritwik Gupta of the Berkeley AI Research Lab returns to talk with Chris about what DeepSeek really means for the AI Industry, Trump’s recent Stargate AI initiative, US-China AI competition, policy responses to DeepSeek, and where we should be looking for the next big disruptive event in the world of AI.

Links:

• https://arxiv.org/abs/2411.14425
• https://www.lawfaremedia.org/article/the-hawley-act-threatens-ai-innovation

#DeepSeek #Stargate #Policy

Send us a text